Jump to content

Alza

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DeprecatedFixerBot (talk | contribs) at 06:16, 14 May 2018 (Removed deprecated parameter(s) from Template:Columns-list using DeprecatedFixerBot. Questions? See Template:Div col#Usage of "cols" parameter or msg TSD! (please mention that this is task #2!))). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ALZA Plaza in Mountain View, California

ALZA Corporation was a pharmaceutical and medical systems company.

Background

Founded in 1968 by Dr Alejandro Zaffaroni; the company's name is a portmanteau of his name. ALZA was a major pioneer in the field of drug delivery systems, bringing over 20 prescription pharmaceutical products to market, and employing about 10,000 people during 20 years.[citation needed] In 2001, ALZA was acquired by Johnson & Johnson via a stock-for-stock transaction worth US$10.5 billion.[1]

Drug delivery platforms

The company owns the patents on the following delivery platforms:

Marketed ALZA Products

Locations

ALZA built its first corporate headquarters in 1971, at 950 Page Mill Road in Palo Alto, California, now occupied by law firm Wilson Sonsini Goodrich & Rosati. In 1999, ALZA moved its headquarters to Shoreline Business Park, where it remained until July 2007 when ALZA was acquired by Johnson & Johnson and the space was vacated.[6][7] The remaining employees were relocated to two buildings elsewhere in the Shoreline Business Park. ALZA is now in operation in Vacaville, California.

Google's Googleplex is located just east of ALZA Plaza. In August–September 2008, Google moved into the ALZA plaza buildings.

ALZA operated a large-scale manufacturing facility in Vacaville, California and previously operated a large-scale facility in Cashel, Ireland.[8]

See also

References

  1. ^ "Johnson & Johnson to Merge With ALZA Corporation In $10.5 Billion Stock-for-Stock Transaction" (Press release). NEW BRUNSWICK, N.J. and MOUNTAIN VIEW, Calif: Johnson & Johnson. Johnson & Johnson. 27 March 2001. Retrieved 10 July 2015.
  2. ^ Gareth Macdonald (28 April 2009). "Patheon to make Oros-based depression and allergy drugs". Decision News Media SAS.
  3. ^ Center for Drug Evaluation and Research (9 May 1995). "Approval Package For: Application Number: NDA 20-021/S-003" (PDF). Retrieved 10 July 2015.
  4. ^ "Bayer to Market ALZA's Viadur(TM) in U.S." (Press release). MOUNTAIN VIEW, Calif., and WEST HAVEN, Conn.: PRNewswire. PRNewswire. 5 April 2000. Retrieved 10 July 2015.
  5. ^ "Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008" (Press release). WAYNE, N.J.: PRNewswire. PRNewswire. 20 December 2007. Retrieved 10 July 2015.
  6. ^ Simonson, Sharon (26 August 2007). "''ALZA's exit could mean another office space buy for Google'' - Silicon Valley/San Jose Business Journal". Sanjose.bizjournals.com. Retrieved 29 July 2011.
  7. ^ "''ALZA Corp. leaving city after 17 years'' - Mountain View Voice". Mv-voice.com. Archived from the original on 24 July 2011. Retrieved 29 July 2011. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  8. ^ "'Devastating' Jobs Blow for Cashel and Tipperary with Closure of Alza/Cordis Plant". Retrieved 7 November 2016.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Alza&oldid=841132557"